Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine-Reference-Cited by-同舟云学术

Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine

Published:2015-12-24 Issue:9 Volume:57 Page:2204-2207
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Isono Noriko,Imai Yoichi,Watanabe Aya,Moriya Keiichi,Tamura Hideto,Inokuchi Koiti,Asano Chihiro,Masuda Michihiko,Shimura Hanae,Mitsuhashi Kenjiro,Kazama Hiroshi,Sugimori Hiroki,Motoji Toshiko,Tanaka Junji

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1126589

Reference15 articles.

1. Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

2. Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

3. Bendamustine can severely impair T-cell immunity against cytomegalovirus

4. Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience;Leukemia & Lymphoma;2022-10-12

3. Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections;Hematology;2022-05-11

4. Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL;Blood Reviews;2021-03

5. Cytomegalovirus Reactivation After Bendamustine-Based Chemotherapy;Infectious Diseases in Clinical Practice;2021-02-19